Rolf Ljung

Seniorprofessor
Fler filtreringsmöjligheter
  1. 2019
  2. Targeted re-sequencing of F8, F9 and VWF: Characterization of Ion Torrent data and clinical implications for mutation screening

    Manderstedt, E., Nilsson, R., Lind-Halldén, C., Rolf Ljung, Jan Astermark & Halldén, C., 2019 apr 26, I : PLoS ONE. 14, 4, e0216179.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Mode of delivery in hemophilia: Vaginal delivery and cesarean section carry similar risks for intracranial hemorrhages and major bleeds

    Andersson, N. G., Chalmers, E. A., Kenet, G., Rolf Ljung, Mäkipernaa, A., Chambost, H. & PedNet Haemophilia Research Foundation, 2019 feb 21, I : Haematologica.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication, and strategies for difficult-to-treat patients

    Rolf Ljung, Auerswald, G., Benson, G., Dolan, G., Duffy, A., Hermans, C., Jiménez-Yuste, V., Lambert, T., Morfini, M., Zupančić-Šalek, S. & Santagostino, E., 2019 feb, I : European Journal of Haematology. 102, 2, s. 111-122

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  5. Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies

    Volkers, P., Hanschmann, K-M., Calvez, T., Chambost, H., Collins, P. W., Demiguel, V., Hart, D. P., Hay, C. R. M., Goudemand, J., Rolf Ljung, Palmer, B. P., Santagostino, E., van Hardeveld, E. M., van den Berg, M. & Keller-Stanislawski, B., 2019, I : Haemophilia. 25, 3, s. 398-407

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Sports participation and physical activity in adult Dutch and Swedish patients with severe haemophilia: A comparison between intermediate- and high-dose prophylaxis

    Versloot, O., Erik Berntorp, Petrini, P., Rolf Ljung, Jan Astermark, Holmström, M., de Kleijn, P. & Fischer, K., 2019, I : Haemophilia. 25, 2, s. 244-251

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. 2018
  8. Practical aspects of extended half-life products for the treatment of haemophilia

    Lambert, T., Benson, G., Dolan, G., Hermans, C., Jiménez-Yuste, V., Rolf Ljung, Morfini, M., Zupančić-Šalek, S. & Santagostino, E., 2018 sep, I : Therapeutic advances in hematology. 9, 9, s. 295-308 14 s.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  9. How I manage patients with inherited haemophilia A and B and factor inhibitors

    Rolf C.R. Ljung, 2018 feb, I : British Journal of Haematology. 180, 4, s. 501-510

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  10. Haemophilia B: Where are we now and what does the future hold?

    Dolan, G., Benson, G., Duffy, A., Hermans, C., Jiménez-Yuste, V., Lambert, T., Rolf Ljung, Morfini, M. & Zupančić Šalek, S., 2018 jan, I : Blood Reviews. 32, 1, s. 52-60

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  11. Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical management

    Benson, G., Auerswald, G., Dolan, G., Duffy, A., Hermans, C., Rolf Ljung, Morfini, M. & Šalek, S. Z., 2018, I : Blood Transfusion. s. 535-544

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  12. Prevention and Management of Bleeding Episodes in Children with Hemophilia

    Rolf C.R. Ljung, 2018, I : Pediatric Drugs. 20, 5, s. 455-464

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. 2017
  14. Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors

    Mancuso, M. E., Fischer, K., Santagostino, E., Oldenburg, J., Platokouki, H., Escuriola-Ettingshausen, C., Rivard, G. E., Cid, A. R., Carcao, M., Ljung, R., Petrini, P., Altisent, C., Kenet, G., Kurnik, K., Auerswald, G., Chambost, H., Mäkipernaa, A., Molinari, A. C., Williams, M., van den Berg, H. M. & 1 andraEuropean Pediatric Network for Haemophilia Management (PedNet) the REMAIN (REal life MAnagement of children with INhibitors) Study Group, 2017 dec, I : Thrombosis and Haemostasis. 117, 12, s. 2274-2282

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. The care of a child with a newly diagnosed immune thrombocytopenia

    Rolf Ljung, 2017 okt 1, I : Acta Paediatrica, International Journal of Paediatrics. 106, 10, s. 1554-1555

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  16. Outcome measures for adult and pediatric hemophilia patients with inhibitors

    Hermans, C., Auerswald, G., Benson, G., Dolan, G., Duffy, A., Jiménez-Yuste, V., Rolf Ljung, Morfini, M., Lambert, T., Mehdi Osooli & Zupančić Šalek, S., 2017 aug 1, I : European Journal of Haematology. 99, 2, s. 103-111 9 s.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  17. Beyond stopping the bleed: short-term episodic prophylaxis with recombinant activated factor FVII in haemophilia patients with inhibitors.

    Šalek, S. Z., Auerswald, G., Benson, G., Dolan, G., Duffy, A., Hermans, C., Jiménez-Yuste, V., Rolf Ljung, Morfini, M., Santagostino, E. & Lambert, T., 2017, I : Blood Transfusion. 15, s. 77-84

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B

    K. Kihlberg, Strandberg, K., Rosén, S., R. Ljung & J. Astermark, 2017, I : Haemophilia. 23, 4, s. 620-627

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Intracranial haemorrhage in children and adolescents with severe haemophilia A or B - the impact of prophylactic treatment

    Gretenkort Andersson, N., Auerswald, G., Barnes, C., Carcao, M., Dunn, A. L., Fijnvandraat, K., Hoffmann, M., Kavakli, K., Kenet, G., Kobelt, R., Kurnik, K., Liesner, R., Mäkipernaa, A., Manco-Johnson, M. J., Mancuso, M. E., Molinari, A. C., Nolan, B., Perez Garrido, R., Petrini, P., Platokouki, H. E. & 3 andraShapiro, A. D., Wu, R. & Rolf Ljung, 2017, I : British Journal of Haematology. 179, 2, s. 298-307

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Plasma products do not solve the inhibitor problem

    van den Berg, H. M., Pipe, S. & R. Ljung, 2017, I : Haemophilia. 23, 3, s. 346-347

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  21. Primary prophylaxis in haemophilia care: Guideline update 2016

    Fischer, K. & Rolf Ljung, 2017, I : Blood Cells, Molecules, and Diseases. 67, s. 81-85

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. 2016
  23. Primary prophylaxis in haemophilia care: Guideline update 2016

    Fischer, K. & Rolf Ljung, 2016 nov 14, (Accepted/In press) I : Blood Cells, Molecules, and Diseases.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Aspects of prophylactic treatment of hemophilia

    Rolf Ljung, 2016 okt 4, I : Thrombosis Journal. 14, S.1, 30.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  25. Inhibitor development in previously untreated patients with severe haemophilia A: a nationwide multicentre study in Finland

    Vepsäläinen, K., Lassila, R., Arola, M., Huttunen, P., Koskinen, S., R. Ljung, Lähteenmäki, P., Möttönen, M. & Riikonen, P., 2016 sep 1, I : Haemophilia. 22, 5, s. 721-729 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. Phenotype and genotype comparisons in carriers of haemophilia A

    Olsson, A., R Ljung, Hellgren, M., E Berntorp & Baghaei, F., 2016 maj, I : Haemophilia. 22, 3, s. 235–237

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Increased inhibitor incidence in severe haemophilia A since 1990 attributable to more low titre inhibitors

    van den Berg, H. M., Hashemi, S. M., Fischer, K., Petrini, P., Rolf Ljung, Rafowicz, A., Carcao, M., Auerswald, G., Kurnik, K., Kenet, G. & Santagostino, E., 2016 apr 1, I : Thrombosis and Haemostasis. 115, 4, s. 729-737 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. BAY 81-8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial.

    Rolf Ljung, Kenet, G., Mancuso, M. E., Kaleva, V., Rusen, L., Tseneklidou-Stoeter, D., Michaels, L. A., Shah, A., Hong, W. & Maas Enriquez, M., 2016, I : Haemophilia. 22, 3, s. 354-360

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. Evaluating outcome of prophylaxis in haemophilia: objective and self-reported instruments should be combined.

    Fischer, K., Nijdam, A., Holmström, M., Petrini, P., Rolf Ljung, van der Schouw, Y. T. & Berntorp, E., 2016, I : Haemophilia.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. Origin of mutation in sporadic cases of severe haemophilia A in Sweden.

    Annika Mårtensson, Sten Ivarsson, Letelier, A., Manderstedt, E., Halldén, C. & Rolf Ljung, 2016, I : Clinical Genetics. 90, 1, s. 63-68

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. Pain and pain management in haemophilia

    Auerswald, G., Dolan, G., Duffy, A., Hermans, C., Jiménez-Yuste, V., Rolf Ljung, Morfini, M., Lambert, T. & Šalek, S. Z., 2016, I : Blood Coagulation and Fibrinolysis. 27, 8, s. 845-854

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  32. Practical considerations in choosing a factor VIII prophylaxis regimen: Role of clinical phenotype and trough levels.

    Rolf Ljung, Fischer, K., Carcao, M., Santagostino, E., Manco-Johnson, M. J. & Mathew, P., 2016, I : Thrombosis and Haemostasis. 115, 5, s. 913-920

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  33. 2015
  34. Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades.

    Nijdam, A., Altisent, C., Carcao, M. D., Cid, A. R., Claeyssens-Donadel, S., Kurnik, K., Rolf Ljung, Nolan, B., Petrini, P., Platokouki, H., Rafowicz, A., Thomas, A. E. & Fischer, K., 2015, I : Haematologica. 100, 3, s. E84-E86

    Forskningsoutput: TidskriftsbidragLetter

  35. Can a "center effect" explain the higher frequency of inhibitors for a second generation recombinant factor VIII product?

    van den Berg, H. M. & Rolf Ljung, 2015, I : Blood. 126, 18, s. 2164-2165

    Forskningsoutput: TidskriftsbidragLetter

  36. Hematologi

    Rolf Ljung, 2015, Neonatologi . Lagercrantz, H., Hellström-Westas, L. & Norman, M. (red.). 2 red. Lund: Studentlitteratur AB, s. 237-246 20

    Forskningsoutput: Kapitel i bok/rapport/Conference proceedingKapitel samlingsverk

  37. How to achieve full prophylaxis in young boys with severe haemophilia A: different regimens and their effect on early bleeding and venous access

    Nijdam, A., Kurnik, K., Liesner, R., Rolf Ljung, Nolan, B., Petrini, P. & Fischer, K., 2015, I : Haemophilia. 21, 4, s. 444-450

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. Mutation analysis of Swedish haemophilia B families - high frequency of unique mutations.

    Annika Mårtensson, Letelier, A., Halldén, C. & Rolf Ljung, 2015, I : Haemophilia.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. Rationale for individualizing haemophilia care.

    Sørensen, B., Auerswald, G., Benson, G., Elezović, I., Felder, M., Lambert, T., Morfini, M., Remor, E., Salaj, P., Santagostino, E., Salek, S. Z. & Rolf Ljung, 2015, I : Blood Coagulation and Fibrinolysis. 26, 8, s. 849-857

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  40. Switching treatments in haemophilia: is there a risk of inhibitor development?

    Santagostino, E., Auerswald, G., Benson, G., Dolan, G., Jimenez-Yuste, V., Lambert, T., Rolf Ljung, Morfini, M., Remor, E. & Salek, S. Z., 2015, I : European Journal of Haematology. 94, 4, s. 284-289

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  41. Tailoring care to haemophilia patients' needs: which specialty and when?

    Morfini, M., Benson, G., Jiménez-Yuste, V., Rolf Ljung, Mannucci, P. M., Pasta, G., Remor, E. & Šalek, S. Z., 2015, I : Blood Transfusion. 13, 4, s. 644-650

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. Various regimens for prophylactic treatment of patients with haemophilia

    Schwarz, R., Rolf Ljung & Ulf Tedgård, 2015, I : European Journal of Haematology. 94, s. 11-16

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  43. 2014
  44. Similar bleeding phenotype in young children with haemophilia A or B: A cohort study

    Rodin Study group, 2014 nov 1, I : Haemophilia. 20, 6, s. 747-755 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  45. Clotting factor level is not a good predictor of bleeding in carriers of haemophilia A and B.

    Olsson, A., Hellgren, M., Erik Berntorp, Rolf Ljung & Baghaei, F., 2014, I : Blood Coagulation and Fibrinolysis. 25, 5, s. 471-475

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. Definitions in hemophilia: communication from the SSC of the ISTH

    Blanchette, V. S., Key, N. S., Rolf Ljung, Manco-Johnson, M. J., Van Den Berg, H. M. & Srivastava, A., 2014, I : Journal of Thrombosis and Haemostasis. 12, 11, s. 1935-1939

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  47. Factor VIII therapy for hemophilia A: current and future issues

    Aledort, L., Rolf Ljung, Mann, K. & Pipe, S., 2014, I : Expert Review of Hematology. 7, 3, s. 373-385

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  48. Joint disease, the hallmark of haemophilia: What issues and challenges remain despite the development of effective therapies?

    Lambert, T., Auerswald, G., Benson, G., Hedner, U., Jiménez-Yuste, V., Rolf Ljung, Morfini, M., Remor, E., Santagostino, E. & Zupančić Šalek, S., 2014, I : Thrombosis Research. 133, 6, s. 967-971

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  49. Perinatal aspects of haemophilia

    Economou, M., Banov, L. & Rolf Ljung, 2014, I : European Journal of Haematology. 93, s. 21-25

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  50. Prospective observational cohort studies for studying rare diseases: the European PedNet Haemophilia Registry

    Fischer, K., Rolf Ljung, Platokouki, H., Liesner, R., Claeyssens, S., Smink, E. & Van den Berg, H. M., 2014, I : Haemophilia. 20, 4, s. e280-e286

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  51. Textbook of hemophilia: Care of the child with hemophilia

    Rolf Ljung, Erik Berntorp, Hoots, K. & Lee, C. A., 2014, John Wiley & Sons. Third edition red. s. 145-150 5 s. 20

    Forskningsoutput: Kapitel i bok/rapport/Conference proceedingKapitel samlingsverk

  52. 2013
  53. 40K glycoPEGylated, recombinant FVIIa: 3-month, double-blind, randomized trial of safety, pharmacokinetics, and preliminary efficacy in hemophilia patients with inhibitors.

    Rolf Ljung, Karim, F. A., Saxena, K., Suzuki, T., Arkhammar, P., Rosholm, A. & Giangrande, P., 2013, I : Journal of Thrombosis and Haemostasis. 11, 7, s. 1260-1268

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  54. Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A

    Carcao, M. D., van den Berg, H. M., Rolf Ljung & Mancuso, M. E., 2013, I : Blood. 121, 19, s. 3946-3952

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  55. Factor VIII Products and Inhibitor Development in Severe Hemophilia A

    Gouw, S. C., van der Bom, J. G., Rolf Ljung, Escuriola, C., Cid, A. R., Claeyssens-Donadel, S., van Geet, C., Kenet, G., Makipernaa, A., Molinari, A. C., Muntean, W., Kobelt, R., Rivard, G., Santagostino, E., Thomas, A. & van den Berg, H. M., 2013, I : New England Journal of Medicine. 368, 3, s. 231-239

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 3 4 5 Nästa